Artículo

Reassessment of genotype 1 hepatitis c virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment

Guelfo, Javier R.; Macias, Juan; Neukam, Karin; Di Lello, Federico AlejandroIcon ; Mira José Antonio; Merchante, Nicolás; Mancebo, María; Nuñez Torres, Rocío; Pineda, Juan A.; Real. Luis M.
Fecha de publicación: 11/2014
Editorial: American Society for Microbiology
Revista: Journal of Clinical Microbiology
ISSN: 0095-1137
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

The accuracy of LiPA 2.0 for hepatitis C virus 1 (HCV-1) subtype classification was analyzed. LiPA 2.0 genotype results from 101 HCV-1-infected patients were compared to genotype findings determined by direct core sequencing. Eleven (11%) samples were misclassified. Given the influence of the HCV-1-subtype in the anti-HCV therapy response, an alternative classification method is warranted.
Palabras clave: Heptitis C Virus , Genotype , Lipa , Core
 
Archivos asociados
Thumbnail
 
Tamaño: 108.4Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution 2.5 Unported (CC BY 2.5)
Identificadores
URI: http://hdl.handle.net/11336/15782
URL: http://jcm.asm.org/content/52/11/4027.long
DOI: http://dx.doi.org/10.1128/JCM.02209-14
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313243/
Colecciones
Articulos(OCA HOUSSAY)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Citación
Guelfo, Javier R.; Macias, Juan; Neukam, Karin; Di Lello, Federico Alejandro; Mira José Antonio; et al.; Reassessment of genotype 1 hepatitis c virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment; American Society for Microbiology; Journal of Clinical Microbiology; 52; 11; 11-2014; 4027-4029
Compartir
Altmétricas